Infliximab: A Pharmacoeconomic Review of its Use in Rheumatoid Arthritis
Year of publication: |
2004
|
---|---|
Authors: | Lyseng-Williamson, Katherine A. ; Foster, Rachel H. |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 22.2004, 2, p. 107-132
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Adis-Drug-Evaluations | Anti-TNF-alpha-monoclonal-antibody | Cost-analysis | Disease-modifying-antirheumatics | Infliximab | Quality-of-life | Rheumatoid-arthritis |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Quality of Life in Patients with Rheumatoid Arthritis: Which Drugs Might Make a Difference?
Blumenauer, Barbara, (2003)
-
Quality-of-Life Assessment in Rheumatoid Arthritis
Russell, Anthony S., (2008)
-
Sorensen, Jan, (2005)
- More ...
-
Olanzapine: A Pharmacoeconomic Review of its Use in Schizophrenia
Foster, Rachel H., (1999)
-
Risperidone: A Pharmacoeconomic Review of its Use in Schizophrenia
Foster, Rachel H., (1998)
-
Acamprosate: Pharmacoeconomic Implications of Therapy
Foster, Rachel H., (1999)
- More ...